European Journal of Obstetrics & Gynecology and Reproductive Biology
Volume 148, Issue 2 , Pages 135-140 , February 2010

Possible association of folic acid supplementation during pregnancy with reduction of preterm birth: a population-based study

  • A.E. Czeizel

      Affiliations

    • Foundation for the Community Control of Hereditary Diseases, Budapest, Hungary
    • Corresponding Author InformationCorresponding author at: 1026, Budapest, Törökvész lejtő 32, Hungary. Tel.: +36 1 3944712; fax: +36 1 3944712.
    • ,
  • E.H. Puhó

      Affiliations

    • Foundation for the Community Control of Hereditary Diseases, Budapest, Hungary
    • ,
  • Z. Langmar

      Affiliations

    • Second Department of Obstetrics and Gynecology, Semmelweis University, School of Medicine, Budapest, Hungary
    • ,
  • N. Ács

      Affiliations

    • Second Department of Obstetrics and Gynecology, Semmelweis University, School of Medicine, Budapest, Hungary
    • ,
  • F. Bánhidy

      Affiliations

    • Second Department of Obstetrics and Gynecology, Semmelweis University, School of Medicine, Budapest, Hungary

Received 3 February 2009 ,Revised 14 September 2009 ,Accepted 14 October 2009.

References 

  1. Smithells RW, Sheppard S, Wild J, Schorah CJ. Prevention of neural tube defect recurrences in Yorkshire: final report. Lancet. 1982;1:498–499
  2. MRC Vitamin Study Research Group. Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. Lancet. 1991;338:131–137
  3. Czeizel AE, Dudas I. Prevention of the first occurrence of neural-tube defects by periconceptional vitamin supplementation. N Engl J Med. 1992;327:1832–1835
  4. Berry R, Li Z, Erickson JD, et al. Prevention of neural-tube defects with folic acid in China. N Engl J Med. 1999;341:1485–1490
  5. Cziezel AE, Tóth M, Rockenbauer M. A case-control analysis of folic acid supplementation during pregnancy. Teratology. 1996;345–35153_
  6. Czeizel AE, Vargha P. Periconceptional folic acid/multivitamin supplementation and twin pregnancy. Am J Obstet Gynecol. 2004;191:790–794
  7. Mohammed K. Routine folate supplementation in pregnancy. In:  Enkin MW,  Keirse MJCN,  Renfreq MJ,  Nielson JP editor. Pregnancy and Childbirth Module. Cochrane Database Syst Rev Review. 1993;[No. 03158, April]
  8. Haider BA, Bhutta ZA. Multiple-micronutrients supplementation for women during pregnancy. Cochrane Database Syst Rev. 2006;18(October (4)):CD004905
  9. Czeizel AE, Rockenbauer M, Siffel Cs, Varga E. Description and mission evaluation of the Hungarian Case-Control Surveillance of Congenital Abnormalities, 1980–1996. Teratology. 2001;63:176–185
  10. Czeizel AE. The first 25 years of the Hungarian Congenital Abnormality Registry. Teratology. 1997;55:299–305
  11. Czeizel AE, Petik D, Vargha P. Validation studies of drug exposures in pregnant women. Pharmacoepid Drug Safety. 2003;12:409–416
  12. Puho HE, Métneki J, Czeizel AE. Maternal employment status and isolated orofacial clefts in Hungary. Cent Eur J Publ Health. 2004;13:144–148
  13. Bjerkedahl T, Czeizel AER, Hosmer DW. Birth weight of single livebirths and weight specific early neonatal mortality in Hungary and Norway. Paediat Perinat Epidemiol. 1989;3:129–140
  14. Goldenberg RL, Culhane JF, Iams JD, Romero R. Epidemiology of preterm birth. Lancet. 2008;371:75–84
  15. Scholl TO, Hediger ML, Schall JI, et al. Dietary and serum folate: their influence on the outcome of pregnancy. Am J Clin Nutr. 1996;63:520–525
  16. McPartlin J, Halligan A, Scott JM, Darling M, Weir DG. Accelerated folate breakdown in pregnancy. Lancet. 1993;341:148–149
  17. Cikot RJLM, Steegers-Theunissen RPM, Thomas CMG, et al. Longitudinal vitamin and homocysteine levels in normal pregnancy. Br J Nutr. 2001;85:49–58
  18. Czeizel AE, Petik D, Puho HE. Smoking and alcohol drinking during pregnancy. The reliability of retrospective maternal self-reported information. Cent Eur J Publ Health. 2004;12:179–183
  19. Adams J. Statement of the Public Affairs Committee of the Teratology Society on the importance of smoking cessation during pregnancy. Birth Defects Res (Part A). 2003;67:895–899
  20. Siega-Riz AM, Savitz SA, Zeisel SH, et al. Second trimester folate status and preterm birth. Am J Obstet Gynecol. 2000;191:851–857
  21. Vollset SE, Refsum H, Irgens LM, et al. Plasma total homocysteine, pregnancy complications, and adverse pregnancy outcomes: The Hordaland Homocysteine Study. Am J Clin Nutr. 2000;71:962–968
  22. Ronnenberg AG, Goldman MB, Chen D, et al. Preconception homocysteine and B vitamin status and birth outcomes in Chinese women. Am J Clin Nutr. 2002;76:1385–1391
  23. Catov JM, Bodnar LM, Ness RB, et al. Association of periconceptional use and risk of preterm or small-for-gestational-age births. Am J Epidemiol. 2007;166:296–303
  24. Smits LJM, Essed GGM. Short pregnancy intervals and unfavorable pregnancy outcomes: role of folate depletion. Lancet. 2001;358:2074–2077
  25. Bukowski R, Malone FD, Porter FF, et al. Preconceptional folate supplementation and the risk of spontaneous preterm birth: a cohort study. PLoS Med. 2009;6:e10000061
  26. Eskes TKAB. Vascular disease in women. Folate and homocysteine. In:  Massaro EJ,  Rogers JM editor. Folate and Human Development. Totowa, NJ: Humana Press; 2002;p. 299–328
  27. van der Molen EF, Verbruggen B, Nokalova I, et al. Hyperhomocysteinemia and other thrombotic risk factors in women with placental vasculopathy. Br J Obstet Gynaecol. 2000;107:785–791
  28. Ferguson SE, Smith GN, Walker MC. Maternal plasma homocysteine levels in women with preterm premature rupture of membranes. Med Hypotheses. 2001;56:85–90
  29. Johnson WG, Scholl TO, Spychala JR, et al. Common dihydrofolate reductase 19-base deletion allele: a novel risk factors for preterm delivery. Am J Clin Nutr. 2005;81:664–668

PII: S0301-2115(09)00632-0

doi: 10.1016/j.ejogrb.2009.10.016

European Journal of Obstetrics & Gynecology and Reproductive Biology
Volume 148, Issue 2 , Pages 135-140 , February 2010

Article Tools